-
D299476-250mgDihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2).
-
D299476-25gDihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2).
-
D299476-50gDihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2).
-
D299476-5gDihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2).
-
D139369-10mgDihydrotanshinone I.
-
D139369-20mgDihydrotanshinone I.
-
D139369-50mgDihydrotanshinone I.
-
D426589-1mlDihydrotanshinone I.
-
D418599-10mgDiosbulbin B exhibits potential hepatotoxicity. Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.
-
D418599-25mgDiosbulbin B exhibits potential hepatotoxicity. Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.
-
D418599-50mgDiosbulbin B exhibits potential hepatotoxicity. Diosbulbin B has potential anti-tumor effects which may be related to influencing the immune system for the first time.
-
D408362-1mlInformationDioscin (Collettiside III, Saponin) is a saponin extracted and isolated from Polygonatum Zanlanscianense Pamp, showing antitumor activities.In vitroDioscin is extracted and isolated from Polygonatum Zanlanscianense Pamp with IC50 of 2.6,